Please log in to your EMQN account to purchase EQA schemes for 2022. We highly recommend registering for schemes as soon as possible as some schemes may become over subscribed due to high demand.
Interested in joining EMQN? Membership is free! You can click the link below to visit our scheme catalogue to view the available schemes in 2022.
If you have any questions, please do contact us at firstname.lastname@example.org.
Please note: 2022 Germline Schemes are now closed for registration.
Thank you to all who participated in our 2021 Lung Cancer (NSCLC) [Tissue], Melanoma, Colorectal Cancer, PIK3CA in hereditary breast cancer, DNA Sequencing - Sanger, Pharmacogenetics and Oncogene panel testing schemes.
The Provisional ILR and Scheme Summary Report are now available for participants to view on our website. Please log in to your EMQN account to view these documents. You will have received an e-mail noting next steps.
EMQN have recently undergone an organisational review, and as a result our membership scheme is evolving and adapting to fit in with both the needs of our members and our organisation. From 2022, we will be offering our membership at no yearly cost.
Click below to read EMQN’s full statement on our membership scheme changes as well as what’s new for 2022!
We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
We have EQAs for SARS-Cov-2 only, or in conjunction with other major respiratory viruses (RSV, Influenza) available for registration. Use the button below to browse our scheme catalogue.
Membership of EMQN gives your laboratory access to world class resources in genomics to help improve your performance.
Opportunities available: Are you interested in sharing good practice and shaping the quality of diagnostic genomic… https://t.co/9KAWl4PS26
The 2021 Provisional ILRs have been Published: Oncogene Panel - https://t.co/2gdjZpasRX
2022 EMQN SARS-CoV-2 EQA schemes – Register Now! - https://t.co/7oDSxmiMeB
The deadline for submitting appeals is approaching... - https://t.co/k8MRCdVHn3